Navigation Links
Genetics May Help Fine-Tune Warfarin Dosage
Date:2/18/2009

Formula that includes DNA data proves faster, more accurate in early tests

WEDNESDAY, Feb. 18 (HealthDay News) -- A DNA test could make prescribing the widely used anticoagulant warfarin safer by predicting the lowest effective dose, a new study finds.

The U.S. Food and Drug Administration estimates that 2 million Americans take warfarin to prevent potentially dangerous blood clots that can cause strokes. Reasons range from implantation of an artificial heart valve to the abnormal heartbeat called atrial fibrillation. But establishing and maintaining the ideal dose is done by trial and error, with weekly and monthly monitoring.

"In a very large group of patients, we showed that the use of genetics helps predict the right dose, and this may take the dangerous guesswork out of prescribing warfarin," said Dr. Russ Altman, a professor of bioengineering, genetics and medicine at Stanford University School of Medicine and a co-author of the study. This "may be one of the first widely-used examples of pharmacogenetics -- the use of genetic information to make better prescribing decisions," he said.

Because an effective dose of warfarin can vary as much as 10-fold from one person to the next, doctors start most people on a low dose and increase it until blood tests indicate the dose is correct. That process can take months.

For the study, which is published in the Feb. 19 issue of the New England Journal of Medicine, researchers collected demographic and genetic data on people at risk for stroke, heart disease and other problems related to blood clotting. The ideal doses of warfarin for these individuals had already been established by trial and error.

In addition, they looked at variants of two genes: CYP2C9, which affects how the liver activates and excretes warfarin, and VKORC1, which activates vitamin K, essential for blood clotting.

They used the data to create an algorithm that
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Genetics Hold Promise, Challenges for Cancer Care
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
4. Obesity genetics
5. The genetics of MLL leukemogenesis
6. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
7. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
8. Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference
9. Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7
10. Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday, November 14, 2007
11. Response Genetics Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetics May Help Fine-Tune Warfarin Dosage
(Date:7/4/2015)... York, NY (PRWEB) , ... July 04, 2015 , ... When a hacker gains access ... home front and at the office. On Wednesday, July 1st, the FTC issued a ... credentials as part of a verification process for a password reset instigated by the hacker. ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June 30th ... new SEO training system called "Page One Engine" . The program, which ... received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. ... been retained to lead a national president recruitment for Regional Care, ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients ... existing Talcum Powder Cancer Lawsuit Center website. Just as the previous version did, the ... , offering timely lawsuit updates and ovarian cancer warning information. The site is routinely ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer ... week that he says will reveal biblical truth and expose popular lies regarding proper ... Bible Say Don’t Have Sex”, immediately goes into the core of the subject by ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... VA, Washington DC, FREDERICKSBURG, Va., Oct. 28 ... 500 percent increase in the number of,patients seeking ... age spots, sun damage, melasma (brown skin patches),acne ... The doctors suggest that increased demand for ...
... ATLANTA, Oct. 28 As October, Breast Cancer ... Blue Shield of Georgia (BCBSGa),understands that it is ... to further improve breast cancer care and awareness ... designed for patients with breast,cancer and their physicians, ...
... from Orrick, Herrington & Sutcliffe Law Firm to Present ... Better ... Experiences, SANTA CLARA, Calif., Oct. 28 Agito ... today,announced that one of its enterprise fixed mobile convergence ...
... Tianyin,Pharmaceutical, Co., Inc., (Amex: TPI ), a ... based in Chengdu, China,today announced that the Company,s ... repurchase program., On October 27, 2008, the ... to $3.0 million of its common stock through ...
... Catalyst,Biosciences, Inc., a pioneer in the discovery ... has appointed Todd Lorenz,M.D., as the company,s Chief ... of experience focused on the clinical,development of novel ... Lorenz to the Catalyst team," said,Nassim Usman, Ph.D., ...
... costs and medical crises fuel many foreclosures, bankruptcies , , ... Deborah Krinsky of Magalia, Calif., have seen their health ... their health-care costs have put them in a financial ... potential heart problems, Deborah,s connective tissue disorder and fallen ...
Cached Medicine News:Health News:Fraxel(R) Laser at Plastic Surgery Services of Fredericksburg Proves Popular Treatment in Cost-Conscious Economy 2Health News:Blue Cross and Blue Shield of Georgia Expands Breast Cancer Care Program 2Health News:Blue Cross and Blue Shield of Georgia Expands Breast Cancer Care Program 3Health News:Agito Networks Customer Selected to Present at the Mobile Enterprise Executive Summit 2008 Conference 2Health News:Agito Networks Customer Selected to Present at the Mobile Enterprise Executive Summit 2008 Conference 3Health News:Agito Networks Customer Selected to Present at the Mobile Enterprise Executive Summit 2008 Conference 4Health News:Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program 2Health News:Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program 3Health News:Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer 2Health News:Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer 3Health News:Medical Debt Sending Many Over Financial Brink 2Health News:Medical Debt Sending Many Over Financial Brink 3
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., ... therapeutics, including those with rare and orphan inflammatory disease ... the U.S. Food and Drug Administration (FDA) to begin ... candidate, acebilustat (CTX-4430), in adult CF patients in the ... Europe will be filed soon ...
(Date:7/6/2015)... FRANCISCO, Calif. , July 6, 2015 ... pharmaceutical company, and Oculeve, a development-stage medical device company ... today announced that they have entered into an agreement ... transaction.  Under the terms of the agreement, Allergan will ... commercialization milestone payments related to Oculeve,s lead development program ...
(Date:7/6/2015)... , July 6, 2015 China Information Technology, Inc. ... provider of integrated cloud-based platform, exchange, and big data ... that the Company launched its mobile app for Healthcare ... healthcare services on mobile devices. The Company jointly hosted ... Family Planning Bureau and Shenzhen News Net.   ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... Naviscan, Inc., the worldwide leader in 3D Molecular ... PhD has joined the Naviscan Board of Directors. ... related to reimbursement in the medical device industry.  He ... Reimbursement at Acclarent, Inc.  After acquisition by Ethicon, Inc., ...
... Calif., July 14, 2011 Molecular Devices, LLC, ... & development, life science research, and bioassay/test development, ... Accreditation (A2LA) has accredited the Laboratory Quality System ... re-calibration processes. (Logo: http://photos.prnewswire.com/prnh/20100406/SF82092LOGO ...
Cached Medicine Technology:Naviscan Further Strengthens its Board of Directors With the Addition of Dr. Andre Cheng 2Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation 2
... 700 Series is an advanced three-part inflatable prosthesis ... a pump placed in the scrotum and a ... It closely simulates the look and performance of ... penile implant technology, the AMS 700 Series now ...
... is an advanced three-part inflatable prosthesis consisting of ... placed in the scrotum and a pair of ... simulates the look and performance of a natural ... technology, the AMS 700 Series now features the ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
Medicine Products: